[Latest] Global 3D Cell Culture Market Size/Share Worth USD 4.6 Billion by 2033 at a 11.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
18 avr. 2024 12h30 HE
|
Custom Market Insights
Austin, TX, USA, April 18, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “3D Cell Culture Market Size, Trends and Insights By Product (Scaffolds Based 3d...
Loop-mediated Isothermal Amplification (LAMP) Market revenue to cross USD 180 Million by 2033, says Research Nester
25 sept. 2023 07h12 HE
|
Research Nester
New York, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The global Loop-mediated Isothermal Amplification (LAMP) Market size is projected to expand at ~ 6% CAGR between 2023 and 2033. The market is expected to...
Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
16 nov. 2021 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results
20 oct. 2021 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
04 févr. 2021 16h02 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Financial Results
07 janv. 2021 16h02 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing
03 mars 2020 08h00 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and HINXTON, United Kingdom, March 03, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an industry leader in microfluidics technology, and Next Gen...
Fluidigm Provides Preliminary Financial Results for Fourth Quarter and Fiscal Year 2019
14 janv. 2020 08h30 HE
|
Fluidigm Corporation
Fourth quarter preliminary revenue of $32.0-32.4 million Fiscal year preliminary revenue of $116.7-117.2 million Mass cytometry revenue increased approximately 23 percent for the full fiscal year ...
MOgene Selects Fluidigm Advanta Assays and Juno System to Expand Its NGS Services Portfolio
13 janv. 2020 08h30 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- MOgene, a leading provider of genomic and bioinformatic services in St. Louis, today announced it has selected Fluidigm’s (NASDAQ:FLDM)...
Fluidigm Announces Conference Call and Webcast of Third Quarter 2019 Financial Results
10 oct. 2019 16h10 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...